Micronoma Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Micronoma is a San Diego–based biotechnology research company focused on early cancer detection through liquid biopsy techniques that interrogate microbial signals with clinical-grade accuracy. Founded in 2019, the company aims to identify microbial biomarkers capable of predicting cancer and potential recurrence, seeking to improve the diagnostic process for individuals facing cancer. Its work positions it at the intersection of microbiome science and oncology, addressing the need for earlier, noninvasive cancer detection. The organization has pursued partnerships and leadership appointments to advance its development, including a collaboration with New York University on a National Cancer Institute–funded project related to non-small cell lung cancer, and the addition of leadership roles in corporate communications, quality, and business development. Micronoma’s activities are anchored in its core platform for microbiome-driven, liquid biopsy-based cancer detection.